Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-22-038582
Date:2022-06-17
Issuer: VERA THERAPEUTICS, INC. (VERA)
Original Submission Date:

Reporting Person:

CURLEY JOANNE
C/O VERA THERAPEUTICS, INC.
8000 MARINA BOULEVARD, SUITE 120 BRISBANE, CA 94005

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
CLASS A COMMON STOCK 2022-06-17 M 1,346 a $6.37 26,540 direct
CLASS A COMMON STOCK 2022-06-17 S 1,346 d $15.08 25,194 direct
CLASS A COMMON STOCK 2022-06-17 M 3,341 a $2.90 28,535 direct
CLASS A COMMON STOCK 2022-06-17 S 3,341 d $15.03 25,194 direct
CLASS A COMMON STOCK 2022-06-17 S 1,200 d $15.05 23,994 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 6.3728 2022-06-17 deemed execution date M 1,346 (d) 2030-03-31 class a common stock 1,346 $6.37 24,145 direct
STOCK OPTION (RIGHT TO BUY) 2.8968 2022-06-17 deemed execution date M 3,341 (d) 2030-12-15 class a common stock 3,341 $2.90 62,681 direct
Footnotes
IDfootnote
f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on april 13, 2022.
f2 the price reported is a weighted-average price. these shares were sold in multiple transactions at prices ranging from $15.00 to $15.33, inclusive. the reporting person will provide upon request to the staff of the securities and exchange commission, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
f3 the price reported is a weighted-average price. these shares were sold in multiple transactions at prices ranging from $15.00 to $15.26, inclusive. the reporting person will provide upon request to the staff of the securities and exchange commission, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
f4 the price reported is a weighted-average price. these shares were sold in multiple transactions at prices ranging from $15.00 to $15.21, inclusive. the reporting person will provide upon request to the staff of the securities and exchange commission, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
f5 1/4 of the shares subject to the option vested on march 12, 2021, and 1/48 of the shares vest monthly thereafter.
f6 1/4 of the shares subject to the option vest on december 16, 2021, and 1/48 of the shares vest monthly thereafter.
WhaleWisdom Logo

Elevate your investments